Inventor · disambiguated record
Gerold L. Mosher
Also filed as: MOSHER GEROLD L
66 granted patents·16 pending applications·1,154 citations·filing 1990–2024
99Inventor score
Files withSILVERGATE PHARMACEUTICALS INC24CYDEX PHARMACEUTICALS INC23AZURITY PHARMACEUTICALS INC14PIPKIN JAMES D7MOSHER GEROLD L5
Top patents by PatentIndex Score
82 records- 0198US11771733B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2021·Granted Oct 3, 2023·4 cites·20 claims
- 0298US11179434B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2021·Granted Nov 23, 2021·7 cites·18 claims
- 0398US10940177B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Mar 9, 2021·8 cites·19 claims
- 0498US10265370B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2018·Granted Apr 23, 2019·10 cites·20 claims
- 0598US10039800B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Aug 7, 2018·12 cites·20 claims
- 0698US9814751B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Nov 14, 2017·13 cites·20 claims
- 0798US9616096B1Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2016·Granted Apr 11, 2017·23 cites·20 claims
- 0898US9463183B1Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2015·Granted Oct 11, 2016·35 cites·13 claims
- 0998US7629331B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2009·Granted Dec 8, 2009·68 cites·18 claims
- 1097US12186360B2Lisinopril formulationsAZURITY PHARMACEUTICALS INC·Filed 2024·Granted Jan 7, 2025·2 cites·19 claims
- 1197US12128083B2Lisinopril formulationsAZURITY PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·2 cites·19 claims
- 1297US11918685B2Amlodipine formulationsAZURITY PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·3 cites·23 claims
- 1397US11701326B2Amlodipine formulationsAZURITY PHARMACEUTICALS INC·Filed 2022·Granted Jul 18, 2023·4 cites·19 claims
- 1497US10959991B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Mar 30, 2021·4 cites·20 claims
- 1597US10952998B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Mar 23, 2021·6 cites·30 claims
- 1697US10894039B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Jan 19, 2021·8 cites·19 claims
- 1797US10695329B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Jun 30, 2020·14 cites·14 claims
- 1897US10406199B2Lisinopril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2019·Granted Sep 10, 2019·8 cites·20 claims
- 1997US9808442B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Nov 7, 2017·8 cites·30 claims
- 2097US9669008B1Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2016·Granted Jun 6, 2017·13 cites·20 claims
- 2197US8835407B2Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the sameMOSHER GEROLD L·Filed 2012·Granted Sep 16, 2014·117 cites·38 claims
- 2297US6046177ASulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulationsCYDEX INC·Filed 1999·Granted Apr 4, 2000·418 cites·95 claims
- 2396US11484498B2Amlodipine formulationsAZURITY PHARMACEUTICALS INC·Filed 2021·Granted Nov 1, 2022·4 cites·26 claims
- 2496US11471409B2Amlodipine formulationsAZURITY PHARMACEUTICALS INC·Filed 2020·Granted Oct 18, 2022·4 cites·29 claims
- 2596US11364230B2Amlodipine formulationsAZURITY PHARMACEUTICALS INC·Filed 2021·Granted Jun 21, 2022·4 cites·25 claims
- 2696US10918621B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·3 cites·30 claims
- 2796US10799476B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2020·Granted Oct 13, 2020·3 cites·14 claims
- 2895US11040023B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2021·Granted Jun 22, 2021·2 cites·20 claims
- 2995US10799453B2Amlodipine formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2019·Granted Oct 13, 2020·7 cites·19 claims
- 3095US8114438B2DPI formulation containing sulfoalkyl ether cyclodextrinPIPKIN JAMES D·Filed 2006·Granted Feb 14, 2012·40 cites·11 claims
- 3195US7034013B2Formulations containing propofol and a sulfoalkyl ether cyclodextrinCYDEX INC·Filed 2002·Granted Apr 25, 2006·105 cites·61 claims
- 3294US10772868B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2019·Granted Sep 15, 2020·3 cites·30 claims
- 3394US10039745B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2017·Granted Aug 7, 2018·4 cites·20 claims
- 3494US8236782B2Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the sameMOSHER GEROLD L·Filed 2010·Granted Aug 7, 2012·30 cites·34 claims
- 3594US8049003B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2008·Granted Nov 1, 2011·18 cites·20 claims
- 3693US12433931B2Lisinopril formulationsAZURITY PHARMACEUTICALS INC·Filed 2024·Granted Oct 7, 2025·0 cites·29 claims
- 3793US12053461B2Amlodipine formulationsAZURITY PHARMACEUTICALS INC·Filed 2022·Granted Aug 6, 2024·1 cites·28 claims
- 3893US10154987B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2018·Granted Dec 18, 2018·3 cites·30 claims
- 3992US8829182B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·7 cites·24 claims
- 4091US12336984B2Amlodipine formulationsAZURITY PHARMACEUTICALS INC·Filed 2024·Granted Jun 24, 2025·0 cites·30 claims
- 4191US8343995B2Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of useCYDEX PHARMACEUTICALS INC·Filed 2008·Granted Jan 1, 2013·17 cites·46 claims
- 4290US8846901B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofMOSHER GEROLD L·Filed 2011·Granted Sep 30, 2014·5 cites·27 claims
- 4389US12383498B2Amlodipine formulationsAZURITY PHARMACEUTICALS INC·Filed 2024·Granted Aug 12, 2025·0 cites·20 claims
- 4489US10786482B2Enalapril formulationsSILVERGATE PHARMACEUTICALS INC·Filed 2018·Granted Sep 29, 2020·1 cites·28 claims
- 4589US10202468B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2017·Granted Feb 12, 2019·2 cites·25 claims
- 4688US6869939B2Formulations containing amiodarone and sulfoalkyl ether cyclodextrinCYDEX INC·Filed 2002·Granted Mar 22, 2005·42 cites·29 claims
- 4787US9399067B2Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2014·Granted Jul 26, 2016·7 cites·22 claims
- 4886US10799599B2Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroidCYDEX PHARMACEUTICALS INC·Filed 2018·Granted Oct 13, 2020·1 cites·12 claims
- 4986US10703826B2Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereofCYDEX PHARMACEUTICALS INC·Filed 2019·Granted Jul 7, 2020·1 cites·20 claims
- 5083US10207008B2Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroidCYDEX PHARMACEUTICALS INC·Filed 2017·Granted Feb 19, 2019·2 cites·21 claims
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gerold L. Mosher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →